MedPath
HSA Approval

VENLEX FORTE XR CAPSULES 150MG

SIN15039P

VENLEX FORTE XR CAPSULES 150MG

VENLEX FORTE XR CAPSULES 150MG

June 22, 2016

PHARMAKOE PTE. LTD.

PHARMAKOE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAKOE PTE. LTD.
Licence HolderPHARMAKOE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE, EXTENDED RELEASE

ORAL

Medical Information

N06AX16

venlafaxine

Manufacturer Information

PHARMAKOE PTE. LTD.

Pharmathen S.A.

Pharmathen International S.A.

Active Ingredients

Venlafaxine hydrochloride 169.71mg equivalent to venlafaxine

150 mg

Venlafaxine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VENLEX FORTE XR CAPSULES 150MG - HSA Approval | MedPath